KM	Homo sapiens	0.57	cholesterol	*recombinant enzyme expressed in baby hamster kidney cells
KM	Homo sapiens	0.83	cholesterol	*recombinant enzyme expressed in hepatic Mc-7777 cells
KM	Homo sapiens	21.4	cholesterol	*in cholesterol-lecithin vesicles
KM	Toxoplasma gondii	0.000026	phosphatidylcholine	*purified recombinant enzyme, pH 7.5, 37&Acirc;&deg;C
KM	Homo sapiens	0.0006	phosphatidylcholine	*radioassay, pH 7.4, 37&Acirc;&deg;C, recombinant enzyme
KM	Homo sapiens	0.0006	1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine	*pH 7.4, 37&Acirc;&deg;C, recombinant wild-type enzyme with mutant A154D/A158D/T161D/A164D apolipoprotein A-I, HDL with a surface charge of -11.3 mV
KM	Homo sapiens	0.001	1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine	*pH 7.4, 37&Acirc;&deg;C, recombinant wild-type enzyme with wild-type apolipoprotein A-I, HDL with a surface charge of -8.2 mV
KM	Homo sapiens	0.027	1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine	*recombinant enzyme, pH 7.4, 37&Acirc;&deg;C
KM	Homo sapiens	0.14	1,2-bis-(1-pyrenebutanoyl)-sn-glycero-3-phosphocholine	*phospholipase activity
KM	Homo sapiens	0.19	1,2-bis-(1-pyrenebutanoyl)-sn-glycero-3-phosphocholine	*phospholipase activity of recombinant enzyme expressed in baby hamster kidney cells
KM	Homo sapiens	0.55	1,2-bis-(1-pyrenebutanoyl)-sn-glycero-3-phosphocholine	*phospholipase activity of recombinant enzyme devoid of sialic acid, expressed in baby hamster kidney cells
KM	Homo sapiens	7.44	1,2-bis-(1-pyrenebutanoyl)-sn-glycero-3-phosphocholine	*
KM	Homo sapiens	10.1	1,2-bis-(1-pyrenebutanoyl)-sn-glycero-3-phosphocholine	*recombinant enzyme expressed in baby hamster kidney cells
KM	Homo sapiens	20.5	1,2-bis-(1-pyrenebutanoyl)-sn-glycero-3-phosphocholine	*recombinant enzyme devoid of sialic acid, expressed in baby hamster kidney cells
KM	Homo sapiens	0.00056	1,2-bis[4-(1-pyreno)butanoyl]-sn-glycero-3-phosphocholine	*fluorescent assay, pH 7.4, 25&Acirc;&deg;C, recombinant enzyme
KM	Homo sapiens	0.003	dehydroergosterol	*recombinant enzyme, pH 7.4, 37&Acirc;&deg;C
KM	Homo sapiens	-999	more	*apparent Km values for LCAT and LAT activities in presence of cholesterol; apparent Km values for LCAT and LAT activities in presence of lysophosphatidylcholine; cholesterol: apparent Km values for LCAT and LAT activities with different apolipoprotein activators; lysophosphatidylcholine: apparent Km values for LCAT and LAT activities with different apolipoprotein activators
KM	Homo sapiens	-999	more	*Km for two naturally occurring mutant enzymes
KM	Homo sapiens	-999	more	*
KM	Homo sapiens	-999	more	*kinetics in presence of wild-type apolipoprotein A-I and different mutants of apolipoprotein A-I
KM	Homo sapiens	-999	more	*Michaelis-Menten kinetics
KM	Homo sapiens	0.000091	apo-A-1	*
MW	Homo sapiens	-999	*	*mass spectrometry analysis gives a range from 55700 to 59600
MW	Homo sapiens	-999	*	*enzyme forms higher aggregates with HDL and apolipoprotein A-I in plasma, overview
MW	Aeromonas salmonicida	23600	*	*x * 23600, SDS-PAGE
MW	Homo sapiens	44000	*	*x * 64000, recombinant glycosylated enzyme, SDS-PAGE, x * 44000, recombinant deglycosylated enzyme, SDS-PAGE
MW	Homo sapiens	46000	*	*x * 46000, SDS-PAGE after cleavage of the N-linked carbohydrates
MW	Homo sapiens	47000	*	*x * 65000-68000, glycosylated protein, SDS-PAGE, x * 47000, deglycosylated enzyme, SDS-PAGE, x * 47089, sequence calculation
MW	Homo sapiens	47089	*	*x * 65000-68000, glycosylated protein, SDS-PAGE, x * 47000, deglycosylated enzyme, SDS-PAGE, x * 47089, sequence calculation
MW	Homo sapiens	49000	*	*recombinant enzyme, gel filtration
MW	Homo sapiens	49000	*	*x * 49000, denatured and deglycosylated enzyme
MW	Sus scrofa	52000	*	*after cleavage of carbohydrate moiety
MW	Homo sapiens	59000	*	*sedimentation equilibrium ultracentrifugation
MW	Homo sapiens	59000	*	*sedimentation equilibrium ultracentrifugation
MW	Homo sapiens	60000	*	*sedimentation equilibrium ultracentrifugation
MW	Homo sapiens	63000	*	*sedimentation equilibrium
MW	Equus caballus	64000	*	*
MW	Gallus gallus	64000	*	*x * 64000, SDS-PAGE
MW	Homo sapiens	64000	*	*x * 64000, recombinant glycosylated enzyme, SDS-PAGE, x * 44000, recombinant deglycosylated enzyme, SDS-PAGE
MW	Homo sapiens	65000	*	*x * 65000, SDS-PAGE
MW	Canis lupus familiaris	65000	*	*x * 65000, SDS-PAGE
MW	Capra hircus	65000	*	*x * 65000, SDS-PAGE
MW	Homo sapiens	65000	*	*x * 65000, SDS-PAGE
MW	Homo sapiens	65000	*	*x * 65000, SDS-PAGE
MW	Homo sapiens	65000	*	*x * 65000, SDS-PAGE
MW	Sus scrofa	66000	*	*HPLC gel filtration
MW	Canis lupus familiaris	66000	*	*HPLC gel filtration
MW	Capra hircus	66000	*	*HPLC gel filtration
MW	Oryctolagus cuniculus	66000	*	*x * 66000, SDS-PAGE
MW	Sus scrofa	66000	*	*
MW	Homo sapiens	66000	*	*x * 66000, SDS-PAGE
MW	Homo sapiens	67000	*	*size exclusion chromatography
MW	Homo sapiens	67000	*	*x * 67000, SDS-PAGE
MW	Homo sapiens	67000	*	*HPLC gel filtration
MW	Oryctolagus cuniculus	67000	*	*HPLC gel filtration
MW	Sus scrofa	67000	*	*HPLC gel filtration
MW	Homo sapiens	67000	*	*x * 67000, SDS-PAGE
MW	Homo sapiens	67000	*	*x * 67000, native enzyme, SDS-PAGE
MW	Homo sapiens	67000	*	*x * 67000, about, recombinant fully glycosylated wild-type enzyme, SDS-PAGE
MW	Homo sapiens	68000	*	*x * 68000, SDS-PAGE
MW	Sus scrofa	69000	*	*x * 69000, SDS-PAGE
MW	Homo sapiens	70000	*	*gel filtration
MW	Homo sapiens	73000	*	*x * 73000, recombinant enzyme, SDS-PAGE
MW	Homo sapiens	83000	*	*gradient gel electrophoresis
MW	Toxoplasma gondii	92000	*	*x * 92000, recombinant enzyme, SDS-PAGE
MW	Homo sapiens	95000	*	*PAGE in absence of SDS
MW	Homo sapiens	95000	*	*gel filtration
PATH	*	Glycerophospholipid metabolism	*	*
SA	Homo sapiens	-999	*	*assay methods
SA	Homo sapiens	-999	*	*assay methods
SA	Homo sapiens	-999	*	*assay methods
SA	Homo sapiens	-999	*	*
SA	Homo sapiens	-999	*	*
SA	Homo sapiens	-999	*	*
SA	Homo sapiens	-999	*	*
SA	Homo sapiens	-999	*	*
SA	Homo sapiens	-999	*	*
SA	Homo sapiens	-999	*	*
SA	Homo sapiens	-999	*	*
SA	Homo sapiens	-999	*	*acyltransferase and esterase activities of several truncated recombinant enzymes
SA	Homo sapiens	-999	*	*patients with Alzheimer's disease have lower LCAT activity in cerebrospinal fluid
SA	Homo sapiens	-999	*	*LCAT activity for several phosphatidylcholine analogs with different chain insaturation
SA	Homo sapiens	-999	*	*recombinant enzyme is half as enzymatically active as plasma LCAT
SA	Homo sapiens	-999	*	*activity of the wild-type and two naturally occurring mutant enzymes
SA	Homo sapiens	-999	*	*cholesterol esterification and phospholipase A2 activities of wild-type and mutant enzymes with different substrates, overview
SA	Homo sapiens	-999	*	*
SA	Homo sapiens	-999	*	*activity with 80 and 93 A HDL particles, and with wild-type and different mutant of apolipoprotein A-I, overview
SA	Homo sapiens	-999	*	*activities produced by different lung cell clones expressing the enzyme
SA	Homo sapiens	-999	*	*
SA	Mus musculus	-999	*	*lipid accumulation in wild-type and LCAT-/- mutant strains, overview
SA	Homo sapiens	-999	*	*LCAT activity in parallel with HDL2 and HDL3 amounts and composition in pregnancy induced hypertension and chronic hypertensive mothers and in their small newborns, overview
SA	Rattus norvegicus	-999	*	*diabetic pregnant rats, Isio-4-fed, show a significant reduction of serum LCAT activity compared to control rats. Isio-4-fed macrosomic pups present a significant increase in serum LCAT activity compared to controls. EPAX diet significantly increases LCAT activity in diabetic dams, whlie it induces a decrease in this activity in macrosomic pups
SA	Homo sapiens	-999	*	*activity of LCAT in men with cardiovascular disease, CVD, compared to healthy men, overview. Plasma LCAT activity is 5% higher in CVD cases in association with higher total cholesterol, non-HDL cholesterol and triglycerides, re-adjusted incident CVD is increased with higher LCAT activity, overview
SA	Homo sapiens	-999	*	*LCAT activity in plasma
SA	Canis lupus familiaris	-999	*	*plasma LCAT activities in dogs fed with diets differing in starch type or low-glycemic index, and oil type or triacylglycerol, overview
SA	Bubalus bubalis	-999	*	*enzyme activity in plasma from healthy buffaloes, and from buffaloes suffering ketosis or haemoglobinuria, overview
SA	Mus musculus	-999	*	*serine palmitoyltransferase deficient mice, and sphingomyelin synthase deficient mice, both of which have below normal sphingomyelin (SM)/phosphatidylcholine (PC) ratios, show significantly elevated LCAT activities when assayed with the endogenous substrates. LDL receptor knockout mice, and apo E knockout mice, both of which have high SM/PC ratios, have reduced LCAT activities
SA	Homo sapiens	-999	*	*enzyme activities with apolipoprotein A-I and Apo AI-derived peptides DRV, KLL, and VLES, overview
SA	Toxoplasma gondii	0.00078	*	*purified recombinant enzyme, pH 7.5, 37&Acirc;&deg;C
SA	Homo sapiens	0.001	*	*recombinant enzyme
SA	Homo sapiens	0.01	*	*in cholesterol-lecithin vesicles activated with apolipoprotein A1, at 37&Acirc;&deg;C and pH 7.1
SA	Homo sapiens	0.06	*	*
SA	Homo sapiens	0.08	*	*
SA	Rattus norvegicus	0.14	*	*in cholesterol-lecithin vesicles activated with rat apolipoprotein A1
SA	Sus scrofa	0.15	*	*in cholesterol-lecithin vesicles activated with porcine apolipoprotein A1
SA	Homo sapiens	0.217	*	*purified recombinant enzyme, pH 7.4, 37&Acirc;&deg;C, substrates are 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine and dehydroergosterol
SA	Homo sapiens	0.27	*	*in cholesterol-lecithin vesicles activated with apolipoprotein A1
SA	Homo sapiens	0.34	*	*at 37&Acirc;&deg;C in cholesterol-lecithin vesicles
SA	Homo sapiens	0.402	*	*purified recombinant enzyme, substrate cholesterol
SA	Homo sapiens	0.42	*	*purified recombinant enzyme, substrate sitosterol
SA	Homo sapiens	0.43	*	*recombinant C-terminal histidine tagged enzyme, similar to plasma enzyme
SA	Sus scrofa	0.47	*	*HDL substrate at 37&Acirc;&deg;C
SA	Homo sapiens	0.54	*	*at 37&Acirc;&deg;C and pH: 7.4
SA	Capra hircus	0.55	*	*in cholesterol-lecithin vesicles activated with human apolipoprotein A1
SA	Oryctolagus cuniculus	0.56	*	*in cholesterol-lecithin vesicles activated with human apolipoprotein A1
SA	Canis lupus familiaris	0.57	*	*in cholesterol-lecithin vesicles activated with apolipoprotein A1
SA	Homo sapiens	0.57	*	*in cholesterol-lecithin vesicles activated with apolipoprotein A1
SA	Sus scrofa	0.59	*	*in cholesterol-lecithin vesicles activated with human apolipoprotein A1
SA	Homo sapiens	0.867	*	*purified recombinant enzyme, pH 7.4, 37&Acirc;&deg;C, substrates are 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine and cholesterol
SA	Homo sapiens	2.7	*	*in cholesterol-lecithin vesicles
SA	Homo sapiens	3.47	*	*in cholesterol-lecithin vesicles activated with apolipoprotein A1
SA	Homo sapiens	53	*	*in cholesterol-lecithin vesicles activated with apolipoprotein A1
SA	Aeromonas salmonicida	137	*	*in cholesterol-lecithin vesicles
